The Federal Hall statue of George Washington overlooks the New York Stock Exchange, Monday, June 7, 2021. Stocks are nudging mostly higher in early trading, putting the S&P 500 and the Dow Jones Industrial Average back near the record highs they reached a month ago. (AP Photo/Richard Drew) NYSE President Stacey Cunningham takes a selfie with a big screen and the opening bell outside the New York Stock Exchange, Monday, June 7, 2021. Stocks are nudging mostly higher in early trading, putting the S&P 500 and the Dow Jones Industrial Average back near the record highs they reached a month ago. (AP Photo/Richard Drew) A woman and her trainer workout outside the New York Stock Exchange, Monday, June 7, 2021. Stocks are nudging mostly higher in early trading, putting the S&P 500 and the Dow Jones Industrial Average back near the record highs they reached a month ago. (AP Photo/Richard Drew)
Stocks edged lower in afternoon trading Monday after briefly approaching the record highs they reached a month ago.
The quiet opening to the week follows several choppy weeks as investors continue to gauge the economy's recovery and the risks rising inflation. Wall Street faces a relatively light week of economic data, though investors will get more information on how much consumer prices rose last month.
The S&P 500 slipped 0.1% as of 3:27 p.m. Eastern. The Dow Jones Industrial Average fell 131 points, or 0.4%, to 34,624 and the Nasdaq rose 0.5%. Small-company stocks far outpaced the rest of the market. The Russell 2000 index rose 1.4%
“The market is treading water right now and waiting for another catalyst to move higher,” said Sam Stovall, chief investment strategist at CFRA.
Technology stocks, banks and industrial companies helped pull the broader market lower. Health care companies made solid gains. Moderna rose 7.9% after it sought a regulatory authorization in Europe to let adolescents receive its COVID-19 vaccine.
Biogen soared 40.2% for the biggest gain in the S&P 500 after the Food and Drug Administration said it approved the company's drug for treating Alzheimer's disease. Biogen's drug is the first Alzheimer's disease treatment approved by the FDA in nearly 20 years.
Treasury yields were stable. The yield on the 10-year Treasury held steady at 1.57%. Crude oil prices were little changed.
Cruise line operators made some of the strongest gains after several companies announced or confirmed plans to start sailing again this summer. The industry essentially shut down during the virus pandemic. Norwegian Cruise Line rose 2.7% and Carnival rose 0.9%.
Corporate buyout plans moved several stocks. U.S. Concrete jumped 29.1% after construction materials company Vulcan Materials said it would buy the company. Design software company Autodesk fell 2.1% after announcing plans to pursue a buyout of Altium.
Investors will get another glimpse into the impact of inflation on Thursday with the Labor Department's consumer price report for May. Prices on everything from food to clothes and housing has been rising as the economy recovers.
Investors and economists are concerned that a steep rise in prices could crimp the recovery and prompt the Federal Reserve to withdraw some of its support for the economy such as keeping interest rates ultra-low and buying bonds.
Markets in Europe were mostly higher, while Asian markets were mixed.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.
Get This Free Report